3.26
Precedente Chiudi:
$2.90
Aprire:
$2.95
Volume 24 ore:
14.22M
Relative Volume:
4.72
Capitalizzazione di mercato:
$889.31M
Reddito:
$8.10M
Utile/perdita netta:
$-92.72M
Rapporto P/E:
-9.5882
EPS:
-0.34
Flusso di cassa netto:
$-82.52M
1 W Prestazione:
+15.19%
1M Prestazione:
+20.30%
6M Prestazione:
+100.00%
1 anno Prestazione:
+57.49%
Taysha Gene Therapies Inc Stock (TSHA) Company Profile
Nome
Taysha Gene Therapies Inc
Settore
Industria
Telefono
(214) 612-0000
Indirizzo
3000 PEGASUS PARK DRIVE, DALLAS
Confronta TSHA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
TSHA
Taysha Gene Therapies Inc
|
3.26 | 774.74M | 8.10M | -92.72M | -82.52M | -0.34 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-11 | Iniziato | BofA Securities | Buy |
2024-06-27 | Iniziato | BMO Capital Markets | Outperform |
2024-04-09 | Iniziato | Piper Sandler | Overweight |
2023-02-01 | Downgrade | Jefferies | Buy → Hold |
2023-01-27 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2022-11-09 | Downgrade | Goldman | Buy → Neutral |
2022-03-09 | Iniziato | Robert W. Baird | Outperform |
2022-03-01 | Iniziato | Wells Fargo | Overweight |
2022-02-18 | Iniziato | SMBC Nikko | Outperform |
2021-12-16 | Iniziato | Guggenheim | Buy |
2021-07-16 | Iniziato | Needham | Buy |
2021-06-24 | Iniziato | Truist | Buy |
2021-06-15 | Iniziato | BTIG Research | Buy |
2021-06-09 | Iniziato | Wedbush | Outperform |
2021-06-08 | Iniziato | JMP Securities | Mkt Outperform |
2021-05-19 | Iniziato | Cantor Fitzgerald | Overweight |
2021-05-11 | Ripresa | Jefferies | Buy |
2021-02-24 | Iniziato | William Blair | Outperform |
2021-01-05 | Iniziato | Oppenheimer | Outperform |
2020-10-19 | Iniziato | Chardan Capital Markets | Buy |
2020-10-19 | Iniziato | Goldman | Buy |
2020-10-19 | Iniziato | Jefferies | Buy |
2020-10-19 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Taysha Gene Therapies Inc Borsa (TSHA) Ultime notizie
Will Taysha Gene Therapies Inc. benefit from sector rotation2025 Pullback Review & Smart Investment Allocation Insights - khodrobank.com
Gains Recap: Can Taysha Gene Therapies Inc. deliver alpha2025 Retail Activity & Stock Portfolio Risk Management - khodrobank.com
How liquid is Taysha Gene Therapies Inc. stockWeekly Earnings Recap & Weekly Top Stock Performers List - khodrobank.com
What’s next for Taysha Gene Therapies Inc. stock priceJuly 2025 WrapUp & Expert Curated Trade Setup Alerts - Newser
What institutional flow reveals about Taysha Gene Therapies Inc.Portfolio Return Report & Weekly High Momentum Picks - Newser
Published on: 2025-09-03 02:33:41 - Newser
Applying big data sentiment scoring on Taysha Gene Therapies Inc.2025 Breakouts & Breakdowns & Real-Time Volume Triggers - Newser
Using data filters to optimize entry into Taysha Gene Therapies Inc.Dollar Strength & Reliable Breakout Forecasts - Newser
Taysha Gene Therapies Inc.’s volatility index tracking explainedJuly 2025 Snapshot & Fast Moving Market Watchlists - Newser
Is Taysha Gene Therapies Inc. a candidate for recovery playMarket Trend Review & Stepwise Trade Signal Implementation - Newser
Will Taysha Gene Therapies Inc. stock go up soonJuly 2025 WrapUp & Advanced Swing Trade Entry Plans - Newser
Taysha Gene Therapies Inc. stock prediction for this weekJuly 2025 Macro Moves & AI Enhanced Trading Signals - Newser
Using portfolio simulators with Taysha Gene Therapies Inc. includedMarket Rally & Low Drawdown Investment Ideas - Newser
Is Taysha Gene Therapies Inc. stock entering bullish territoryJuly 2025 Summary & Scalable Portfolio Growth Methods - Newser
Can Taysha Gene Therapies Inc. outperform under higher oil pricesJuly 2025 Review & Growth Focused Stock Reports - khodrobank.com
How to build a custom watchlist for Taysha Gene Therapies Inc.Profit Target & Accurate Intraday Trading Signals - Newser
How high can Taysha Gene Therapies Inc. stock go2025 Key Lessons & AI Based Buy/Sell Signal Reports - Newser
Is Taysha Gene Therapies Inc. stock reversal real or fakeJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Taysha Gene Therapies Inc. stock volume spike explainedPortfolio Value Summary & Expert Approved Momentum Ideas - Newser
How does Taysha Gene Therapies Inc. perform in inflationary periodsJuly 2025 Sector Moves & Intraday High Probability Setup Alerts - khodrobank.com
Is Taysha Gene Therapies Inc. forming a reversal patternEarnings Recap Summary & Daily Stock Trend Watchlist - Newser
What earnings revisions data tells us about Taysha Gene Therapies Inc.Portfolio Gains Report & Daily Risk Controlled Trade Plans - Newser
Can volume confirm reversal in CleanSpark Inc.July 2025 Price Swings & Accurate Trade Setup Notifications - Newser
RSI Suggests Rebound May Be Near in Taysha Gene Therapies Inc.July 2025 Snapshot & Momentum Based Trading Signals - beatles.ru
Multi asset correlation models including Taysha Gene Therapies Inc.Market Movers & High Accuracy Buy Signal Tips - Newser
Taysha Gene Therapies’ Earnings Call: Progress Amid Challenges - TipRanks
Taysha Gene Therapies Inc. stock daily chart insightsJuly 2025 Retail & Reliable Price Breakout Alerts - Newser
Real time breakdown of Taysha Gene Therapies Inc. stock performanceJuly 2025 Opening Moves & Weekly Momentum Stock Picks - Newser
Real time alert setup for Taysha Gene Therapies Inc. performance2025 Big Picture & Accurate Entry and Exit Point Alerts - Newser
Are Bears Losing Grip on Taysha Gene Therapies Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Real time social sentiment graph for Taysha Gene Therapies Inc.July 2025 Market Mood & High Accuracy Trade Signal Alerts - Newser
Heatmap analysis for Taysha Gene Therapies Inc. and competitorsQuarterly Investment Review & Precise Buy Zone Identification - Newser
Taysha Gene Therapies Inc Azioni (TSHA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Taysha Gene Therapies Inc Azioni (TSHA) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Alam Kamran | CHIEF FINANCIAL OFFICER |
Aug 21 '25 |
Sale |
2.85 |
54,491 |
155,299 |
1,187,603 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):